Sabine Weidner
Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland
Zulewski H, Dettmer M, Minder A, Clerici T, Triponez F, Oertli D, Weidner S, Steinert H, Haldemann A, Christ E, Bilz S, Giovanella L, Komminoth P. Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland. Swiss Med Wkly 2019; 149:w14700.
Jan 27, 2019Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland
Jan 27, 2019Swiss Med Wkly 2019; 149:w14700
Zulewski Henryk, Dettmer Matthias, Minder Anna, Clerici Thomas, Triponez Frederic, Oertli Daniel, Weidner Sabine, Steinert Hans, Haldemann Andreas, Christ Emanuel, Bilz Stefan, Giovanella Luca, Komminoth Paul
Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program
Balmelli C, Stenner F, Pless M, Weidner S, Zimmermann S, Güthner C, Cristina V, Cathomas R, Feuerlein K, Siano M, Railic N, Rothschild S. Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program. J Cancer 2018; 9:250-255.
Jan 1, 2018Lenvatinib in Advanced Radioiodine-Refractory Thyroid Cancer - A Retrospective Analysis of the Swiss Lenvatinib Named Patient Program
Jan 1, 2018J Cancer 2018; 9:250-255
Balmelli Catharina, Stenner Frank, Pless Miklos, Weidner Sabine, Zimmermann Stefan, Güthner Christiane, Cristina Valerie, Cathomas Richard, Feuerlein Kristin, Siano Marco, Railic Nikola, Rothschild Sacha I